(Spanish Version) Patients Whose First Episode of Bleeding Occurs While Taking...

submitted by: gastro@scivee
Dr. Juan G. Abraldes discusses his manuscript "Patients Whose First Episode of Bleeding Occurs While Taking a β-Blocker Have High Long-term Risks of Rebleeding and Death." To view the print version of this abstract go to http://bit.ly/KXtG7o . The content of this video has not been verified by a native speaker of the language being spoken. This video abstract is also available on this channel in English: http://www.scivee.tv/node/48555

(English Version) Patients Whose First Episode of Bleeding Occurs While Taking...

submitted by: gastro@scivee
Dr. Juan G. Abraldes discusses his manuscript "Patients Whose First Episode of Bleeding Occurs While Taking a β-Blocker Have High Long-term Risks of Rebleeding and Death." To view the print version of this abstract go to http://bit.ly/KXtG7o . This video abstract is also available on this channel in Spanish: http://www.scivee.tv/node/48556

Nonpungent capsaicin analogs (capsinoids) increase energy expenditure

submitted by: Yoneshiro
Background: Capsinoids—nonpungent capsaicin analogs—are known to activate brown adipose tissue (BAT) thermogenesis and whole-body energy expenditure (EE) in small rodents. BAT activity can be assessed by [18F]fluorodeoxyglucose–positron emission tomography (FDG-PET) in humans. Objectives: The aims of the current study were to examine the acute effects of capsinoid ingestion on EE and to analyze its relation to BAT activity in humans. Design: Eighteen healthy men aged 20–32 y...
Authors: Takeshi Yoneshiro, Sayuri Aita, Yuko Kawai, Toshihiko Iwanaga, Masayuki Saito

Cancer Research for Stage 1 Lung Cancer

submitted by: mdanderson

New cancer research for stage 1 lung cancer is being investigated at The University of Texas MD Anderson Cancer Center. It’s led by Jack Roth, M.D., professor in the Department of Thoracic and Cardiovascular Surgery. This clinical trial called STARS (Stereotactic Radiation Therapy Verses Surgery) compares a new type of radiation treatment with a traditional surgery approach. Roth describes this promising new treatment and explains how lung cancer patients may get involved.

Dr. Cohen's Clinical Trial for Breast Cancer Patients

submitted by: mdanderson

Lorenzo Cohen, Ph.D., discusses a new clinical trial that will test the effects of lifestyle changes on cancer recurrence. Breast cancer patients in the study will receive coaching on nutrition, exercise, stress reduction and strengthening their social connections.

CYCORE – Information Technology Tools Helping With Clinical Trials

submitted by: mdanderson
CYCORE (Cyberinfrastructure for Comparative Effectiveness Research) was a clinical trial conducted by The University of Texas MD Anderson Cancer Center, University of California-San Diego and University of Alabama at Birmingham, that studied the use of sensing devices to wirelessly send health-related data from the patient’s home to the cancer research facility. The purpose of this study is for other researchers to use CYCORE’s technology to gather more detailed information in their own...

Hope on the Horizon for Pancreatic Cancer Patients

submitted by: mdanderson
Clinical Trial: http://1.usa.gov/PncreasCncr Milind Javle, M.D., associate professor in the Department of Gastrointestinal Medical Oncology at MD Anderson Cancer Center, is offering hope for those faced with pancreatic cancer. Javle is leading a new clinical trial which targets the rapid growth of pancreatic cancer cells. This trial is testing the standard treatment with a new antibody that has shown promising results in the laboratory. Javle says it is believed that every pancreatic...

Targeted drug helps Hodgkin lymphoma patients

submitted by: mdanderson

An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, investigators report in the Nov. 4 issue of the New England Journal of Medicine.

BATTLE Promotes Personalized Approach for Lung Cancer

submitted by: mdanderson

An innovative clinical trial uses tumor biopsy information and unique statistical method to match four drugs to potential biomarkers that might guide treatment. Study leader Dr. Edward Kim of The University of Texas M. D. Anderson Cancer Center discusses BATTLE results.

Methylphenidate Decreased the Amount of Glucose Needed by the Brain to Perform a Cognitive Task

submitted by: noravolkow
The use of stimulants (methylphenidate and amphetamine) as cognitive enhancers by the general public is increasing and is controversial. It is still unclear how they work or why they improve performance in some individuals but impair it in others. To test the hypothesis that stimulants enhance signal to noise ratio of neuronal activity and thereby reduce cerebral activity by increasing efficiency, we measured the effects of methylphenidate on brain glucose utilization in healthy adults. We...
Authors: Nora d. Volkow, Joanna s. Fowler, Gene-jack Wang, Frank Telang, Jean Logan, Christopher Wong, Jim Ma, Kith Pradhan, Helene Benveniste, James m. Swanson